{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:19:17Z","timestamp":1792664357076,"version":"4.5.0"},"reference-count":37,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T00:00:00Z","timestamp":1355961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Research on vision-related quality of life (QOL) in multiple sclerosis (MS) is still limited. Tools such as the Visual Functioning Questionnaire-25 (VFQ-25) and the Vision Performance Scale (VPS) facilitate assessments of the severity of visual impairment and its impact on daily life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The objective of this paper is to examine vision-related QOL, comorbid eye conditions, use of visual aids and utilization of eye-care providers in the North American Research Committee on Multiple Sclerosis (NARCOMS) population, and to explore these issues in those with a history of optic neuritis (ON) and diplopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In 2008, NARCOMS registrants reported on their use of visual aids, the VFQ-25, VPS, history of ON, diplopia, refractive error conditions (REC) and comorbid eye diseases (CED). We conducted regression analyses and correlations between select variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The response rate for the survey was 60.4%. Of the 9107 responders, 66.7% reported visual disability measured by VPS. Of respondents, 43.1% had a history of ON and 38.6% reported prior diplopia. Frequencies of myopia (51.8%), hyperopia (26.6%), and uveitis (3.4%) exceeded those expected for the general population. Mean (SD) VFQ-25 composite score was 82.0 (14.2). A history of ON or diplopia accounted for 9.7% of the variance in the VFQ-25; 90.6% of respondents used glasses or contact lenses. Rates of utilizations of eye-care providers were lower than expected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Prior ON, diplopia, REC and CED adversely impact vision-related QOL in MS. Increased utilization of eye-care providers and use of visual aids could improve vision-related QOL in people with MS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1352458512469694","type":"journal-article","created":{"date-parts":[[2012,12,21]],"date-time":"2012-12-21T02:24:21Z","timestamp":1356056661000},"page":"953-960","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":29,"title":["\u201cSeeing\u201d in NARCOMS: a look at vision-related quality of life in the NARCOMS registry"],"prefix":"10.1177","volume":"19","author":[{"given":"Amber R","family":"Salter","sequence":"first","affiliation":[{"name":"Department of Biostatistics, University of Alabama at Birmingham, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula","family":"Tyry","sequence":"additional","affiliation":[{"name":"Division of Neurology, Barrow Neurological Institute, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Vollmer","sequence":"additional","affiliation":[{"name":"University of Colorado Denver, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R","family":"Cutter","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Alabama at Birmingham, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Manitoba, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2012,12,20]]},"reference":[{"key":"bibr1-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.9.747"},{"key":"bibr2-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.3.473"},{"key":"bibr3-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(05)00992-0"},{"key":"bibr4-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.01.031"},{"key":"bibr5-1352458512469694","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073-12.2.83"},{"key":"bibr6-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.11.1496"},{"key":"bibr7-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2008.165449"},{"key":"bibr8-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)01337-5"},{"key":"bibr9-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.119.7.1050"},{"key":"bibr10-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.04.051"},{"key":"bibr11-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1177\/1352458507078388"},{"key":"bibr12-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1017\/S031716710000860X"},{"key":"bibr13-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2007.12.005"},{"key":"bibr14-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1177\/1352458506075031"},{"key":"bibr15-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1177\/1352458508092263"},{"key":"bibr16-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1177\/135245859900500508"},{"key":"bibr17-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.1.63"},{"key":"bibr18-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199603000-00003"},{"key":"bibr19-1352458512469694","first-page":"1017","volume":"41","author":"Cole SR","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bibr20-1352458512469694","volume-title":"The National Eye Institute 25-Item Visual Function Questionnaire: Scoring algorithm","author":"Mangione CM","year":"1997"},{"key":"bibr21-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2005.10.040"},{"issue":"1","key":"bibr22-1352458512469694","volume":"10","author":"Collins J","year":"1993","journal-title":"Vital Health Stat"},{"key":"bibr23-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1177\/135245859900500511"},{"key":"bibr24-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.477"},{"key":"bibr25-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.8.1111"},{"key":"bibr26-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(92)31774-9"},{"key":"bibr27-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.122.4.487"},{"key":"bibr28-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.06.014"},{"key":"bibr29-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510369146"},{"key":"bibr30-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1177\/1352458507083444"},{"key":"bibr31-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.15.2057"},{"key":"bibr32-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511414041"},{"key":"bibr33-1352458512469694","volume-title":"The Cost of Blindness: What it means to Canadians","author":"Armstrong J"},{"key":"bibr34-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1177\/135245850000600604"},{"key":"bibr35-1352458512469694","doi-asserted-by":"publisher","DOI":"10.3109\/02713681003664931"},{"key":"bibr36-1352458512469694","unstructured":"Centers for Disease Control. Office of Surveillance, Epidemiology, and Laboratory Services Behavioral Risk Factor Surveillance System. About the BRFSS, http:\/\/www.cdc.gov\/brfss\/about.htm (2008, accessed 27 September 2012)."},{"key":"bibr37-1352458512469694","doi-asserted-by":"publisher","DOI":"10.1159\/000311013"}],"container-title":["Multiple Sclerosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458512469694","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1352458512469694","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458512469694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:36:21Z","timestamp":1777692981000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1352458512469694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,20]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1177\/1352458512469694"],"URL":"https:\/\/doi.org\/10.1177\/1352458512469694","relation":{},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,20]]}}}